Micron Technology sits at the centre of the AI‑driven memory supercycle, producing earnings so outsized that they are distorting aggregate S&P 500 beat statistics. Its HBM franchise is sold out for the entire 2026 calendar year, gross margins are tracking towards 81%, and forward guidance implies revenue levels that would have seemed implausible for a…
If you're looking to buy an ASX ETF, you're hardly alone. Australia's ETF market ended 2025 at a record A$330.6bn in funds under management, having attracted A$53bn in net inflows during the year alone, nearly double the previous record set in 2024.
With 545 funds now available across the ASX and Cboe, and nearly 3 million…
The dream of all ASX resources small caps is find the next big mine and bring it into production. This is a journey a handful of companies have made, but one that most fail at. But you have to be hopeful and have to start somewhere. And it all starts with picking up a project.
We thought…
2026 has 8 months to go, but we think that the Nuix Judgement (i.e. the Federal Court’s dismissal of ASIC’s case against Nuix) will be the most consequential corporate law outcome of the year.
The impact goes beyond Nuix and could well influence ASIC's boldness to pursue corporate cases. The judgement clarified that forecasts must be…
Suncorp’s announcement of a new 5‑year aggregate reinsurance arrangement lands at a moment when the group has already undergone one of the most significant strategic resets in its modern history.
The business that once balanced general insurance with a low‑return retail bank has, over the past three years, reshaped itself into a more focused, more predictable…
The imminent US Marijuana Rescheduling begs the question: Is it really different this time for ASX pot stocks? In one sense, perhaps it is, because it is undoubtedly the most significant policy signal in more than 50 years. But in the other, there's no promise it'll lead to anything, as recent history has shown.
What's Happening…
Is there any such thing as safe ASX stocks? Maybe not in the sense of being completely risk-free, but there are some that are doing better than others right now and they are in the minority.
Amidst the latest round of ASX trading updates (spanning consumer, infrastructure and energy), all investors are looking to see if…
ASX Confession Season got into full swing yesterday with Cochlear's guidance downgrade that saw over $4bn in shareholder value wiped out. It is that time that happens every year - a period that fund managers dread and short sellers quietly anticipate. It has no official name on the ASX calendar, no regulatory trigger, and no…
Capital is flowing back into the ASX mining project developers. We thought it was time to write another list of companies that locked in financing deals lately. Not just because it has been a while since the last time, but because the character of this cycle is fundamentally different.
The past six months have not been…
If you own shares in Cochlear (ASX:COH), you had a pretty bad morning. The company delivered one of the most significant earnings guidance downgrades in its listed history this morning, cutting its FY26 underlying net profit guidance to A$290–330m from a previously disclosed range of A$435–460m. The revision (a reduction of roughly 30% at the…
